Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination

Схожі ресурси

• Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination
  за авторством: Espen Basmo Ellingsen, та інші
  Опубліковано: (2022-09-01)
• Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
  за авторством: Sara M Mangsbo, та інші
  Опубліковано: (2022-05-01)
• Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial
  за авторством: Elin Aamdal, та інші
  Опубліковано: (2021-05-01)
• Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential
  за авторством: Espen Basmo Ellingsen, та інші
  Опубліковано: (2021-07-01)
• Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer
  за авторством: Paal F. Brunsvig, та інші
  Опубліковано: (2020-11-01)